We advised the sales agent on the offering

Davis Polk advised the sales agent in connection with the establishment of an SEC-registered at-the-market program by Pacific Biosciences of California, Inc. of shares of its common stock for up to an aggregate amount of $100 million. The common stock is listed on the Nasdaq Global Market under the symbol “PACB.”

Based in Menlo Park, California, Pacific Biosciences is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems.

The Davis Polk corporate team included partner Yasin Keshvargar and associate Jean (Jean Young) Koo. Partner David R. Bauer and associate Anne Kim provided intellectual property advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post